Focus Partners Advisor Solutions LLC Has $762,000 Stock Position in DENTSPLY SIRONA Inc. $XRAY

Focus Partners Advisor Solutions LLC lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 91.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 47,988 shares of the medical instruments supplier’s stock after purchasing an additional 22,894 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in DENTSPLY SIRONA were worth $762,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of DENTSPLY SIRONA by 4.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock valued at $180,445,000 after purchasing an additional 538,531 shares during the period. AQR Capital Management LLC boosted its position in shares of DENTSPLY SIRONA by 119.4% in the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after purchasing an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. lifted its stake in DENTSPLY SIRONA by 26.4% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock worth $43,526,000 after acquiring an additional 609,300 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 0.2%

XRAY opened at $13.07 on Wednesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $11.69 and a fifty-two week high of $24.86. The business has a 50-day moving average of $13.31 and a 200-day moving average of $14.52. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.61 billion, a PE ratio of -2.76, a price-to-earnings-growth ratio of 0.82 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period last year, the business earned $0.49 EPS. The business’s quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio is currently -13.50%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. UBS Group decreased their price objective on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research report on Tuesday. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Barrington Research decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Two research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $17.91.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.